Chemours (CC) Set to Announce Earnings on Tuesday

Chemours (NYSE:CC) will post its quarterly earnings results after the market closes on Tuesday, April 30th. Analysts expect Chemours to post earnings of $0.25 per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

Chemours (NYSE:CC) last issued its earnings results on Wednesday, March 27th. The specialty chemicals company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.02. Chemours had a negative net margin of 3.80% and a positive return on equity of 51.73%. The business had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. On average, analysts expect Chemours to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Chemours Price Performance

Shares of Chemours stock opened at $27.32 on Friday. The company has a debt-to-equity ratio of 5.40, a quick ratio of 1.00 and a current ratio of 1.54. The firm’s 50-day simple moving average is $26.70 and its 200-day simple moving average is $27.82. Chemours has a twelve month low of $15.10 and a twelve month high of $39.05. The firm has a market cap of $4.07 billion, a P/E ratio of -17.63 and a beta of 2.00.

Chemours Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Monday, February 26th were given a dividend of $0.25 per share. The ex-dividend date of this dividend was Friday, February 23rd. This represents a $1.00 annualized dividend and a dividend yield of 3.66%. Chemours’s dividend payout ratio (DPR) is currently -64.52%.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Barclays decreased their target price on shares of Chemours from $32.00 to $30.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 2nd. UBS Group lifted their price target on shares of Chemours from $21.00 to $28.00 and gave the company a “neutral” rating in a report on Tuesday, April 2nd. Finally, BMO Capital Markets raised shares of Chemours from an “underperform” rating to an “outperform” rating and lifted their price target for the company from $19.00 to $34.00 in a report on Tuesday, April 9th. Seven research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, Chemours has a consensus rating of “Hold” and a consensus price target of $30.89.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.